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Abstract
Automated surveillance utilizing electronically available data has been found to be accurate and
save time. An automated CDI surveillance algorithm was validated at four CDC Prevention
Epicenters hospitals. Electronic surveillance was highly sensitive, specific, and showed good to
excellent agreement for hospital-onset; community-onset, study facility associated; indeterminate;
and recurrent CDI.
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It is recommended all US hospitals track Clostridium difficile infection (CDI) (1). At a
minimum it is recommended to conduct surveillance for hospital onset CDI, but tracking
CDI with onset in the community may have important epidemiological and prevention
implications (1–2). However, surveillance for community-onset CDI is much more labor
intensive than hospital-onset CDI. Due to increased demand for patient safety coupled with
an emphasis to adopt and implement electronic health records, automated surveillance
systems for tracking nosocomial infections needed to be investigated to maximize both
limited resources and patient safety (3–4). There were goal of this study was to develop and
validate an automated CDI surveillance algorithm utilizing electronically available data at
multiple healthcare facilities.
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The study population included all adult patients ≥ 18 years of age admitted to four US
hospitals participating in the CDC Epicenters Program from July 1, 2005 to June 30, 2006.
These hospitals included Barnes-Jewish Hospital (St. Louis, MO), Brigham and Women’s
Hospital (Boston, MA), The Ohio State University Medical Center (Columbus, OH), and
University Hospital (Salt Lake City, UT).
A conceptual automated CDI surveillance algorithm was created based on recommended
surveillance definitions (Figure 1) (1). Each center worked with their medical informatics
departments to apply the algorithm to their local databases. CDI case categorizations by the
algorithm were compared to categorizations previously determined by chart review (5). A
second chart review was performed for discordant results. The gold standard comparison
was all concordant cases and the categorization determined to be correct by the re-review.
The algorithms were modified as needed to improve accuracy. Sensitivities and specificities
were calculated for each CDI surveillance definition. Kappa (κ) statistics were also
calculated. Statistical analyses were performed with SPSS for Windows, version 19.0
(SPSS, Inc., Chicago, IL).
RESULTS
There were 1767 patients with stool positive for C. difficile toxins identified. After the
initial comparison of the algorithm’s categorization of CDI cases to categorizations
determined by chart review, hospital A had 204 discordant cases (27.1%), hospital B had 77
(18.7%), hospital C had 55 (22.4%), and hospital D had 104 (29.1%). Data on discordant
cases were submitted back to the appropriate hospitals for re-review.
The overall sensitivities, specificities, and kappa values of the algorithm by CDI onset
compared to the gold standard were as follows: hospital-onset: 92%, 99%, and 0.90;
community-onset, study facility associated: 91%, 98%, and 0.84; community-onset, other
healthcare facility associated: 57%, 99%, and 0.65; community-onset, community-
associated: 96%, 94%, and 0.69; indeterminate cases: 80%, 98%, and 0.76; and recurrent
cases: 94%, 99%, and 0.94 (Table 1). Similar sensitivity, specificity, and Kappa values were
seen at all individual hospitals for community-onset, study-center associated and recurrent
CDI (Table 1). The algorithm had excellent agreement for hospital-onset CDI at each
hospital – except for hospital B. Community-onset, other healthcare facility associated CDI
showed a wide range of sensitivities (16% to 96%) and Kappa values (0.25 to 0.93). Similar
trends were seen for community-onset, community-associated and indeterminate CDI.
Each hospital had to individualize the algorithm to their facility. Hospitals A, B, and C did
not have discrete data on where a patient was admitted from (e.g. admit from home, long
term care facility), whereas hospital D did. Therefore, categorization of community-onset
cases at these hospitals was dependent on the discharge status (e.g. discharge to home, long
term care facility) if the patient had a prior hospitalization in the previous 12 weeks.
Hospital A has a code for patients with frequent outpatient visits called “recurring patients,”
which has a start date of the first visit and end date of December 31. Many “recurring
patients” with CDI were misclassified as hospital-onset CDI. The medical informatics team
created a new table within the database which contained information regarding the visit type
associated with a given encounter to correct this problem. Hospital B made minor
modifications to the hospital-onset time cut-off to improve accuracy. Hospital C was not
able to modify their algorithm because some data was available only through free text fields.
Hospital D initially included patients who were admitted to only one particular building,
missing those patients who were admitted to the other three buildings of their medical
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center. This was corrected. Three other issues were identified and resolved after the initial
review of discordant cases: outpatient encounters were included when determining case
categorization rather than only inpatient encounters; only the first positive C difficile toxin
result per patient was evaluated, so subsequent episodes of CDI were missed; and stool
collection date was used to identify patients instead of the admit date.
DISCUSSION
This goal of this study was to develop and validate an automated CDI surveillance algorithm
utilizing existing electronically available data. Previous research indicates electronic
surveillance is more accurate and reliable than manual surveillance (3, 6). Automated
surveillance also requires less time as it eliminates the need to do chart review. This study
found automated CDI surveillance to be feasible and reliable with overall good to excellent
agreement for hospital-onset; community-onset, study facility associated; indeterminate; and
recurrent CDI case categorizations.
Each hospital worked with their individual information technology teams to apply the
general automated CDI surveillance algorithm to the data available at their facilities. In this
study, data availability and type of data varied from hospital to hospital, thus impacting the
accuracy of the automated algorithm. This issue is illustrated by Hospital D, where hospital
performed the best at categorizing community-onset CDI because there was a discrete
variable that captured where patients were admitted from.
There are potential limitations to the use of an automated CDI surveillance algorithm.
Electronic surveillance requires access to an electronic health record (EHR) system. Only
about 12% of US hospitals have an EHR system (7). To develop an automated algorithm,
surveillance rules need to be specified into electronic algorithm rules. This can lead to
algorithms that vary from site to site based on data availability. As a result, each center can
potentially have different rules for the same infection, resulting in different rates, making
inter-hospital comparisons difficult (3).
Another limitation of using an automated CDI surveillance algorithm is that chart review is
not performed. While the lack of chart review is mitigated by enforcing toxin testing of only
diarrheal stool, misclassification is still possible. It is possible that a true community-onset
CDI case could be misclassified as a hospital-onset CDI case if stool was collected after the
hospital-onset cut-off date. In addition, patients with a positive assay for C. difficile may not
have clinically significant diarrhea, and therefore do not truly have CDI. This may be
especially problematic at hospitals that use nucleic acid amplification tests (8).
This study found automated electronic CDI surveillance to be highly sensitive and specific
for identifying cases of hospital-onset; community-onset, study center-associated; and
recurrent CDI. Automated CDI surveillance will allow infection preventionists to devote
more time to infection prevention efforts. In addition, automated CDI surveillance may
facilitate a healthcare facility’s ability to track community-onset CDI. Community-onset
CDI likely contributes to hospital-onset CDI because patients admitted to a healthcare
facility with CDI are a source of C. difficile transmission to other patients. Understanding
the burden of community-onset CDI may allow for targeting of CDI prevention efforts (2).
Implementing an automated algorithm utilizing electronically available data is feasible and
reliable.
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Conceptual automated CDI surveillance algorithm.
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